The most commonly reported side effects include: Nausea, Diarrhoea, Vomiting, Mild stomach discomfort
Panesar PS et al
FuYHeYPhanKBhatiaSPickfordRWuPet al
Use of FARXIGA for this indication is supported by a 26-week placebo-controlled trial with a 26-week extension in 157 pediatric patients aged 10 to 17 years with type 2 diabetes mellitus, pediatric pharmacokinetic data, and trials in adults with type 2 diabetes mellitus [see Clinical Pharmacology (12.3) and Clinical Studies (14.1, 14.2)]
Because NPs differ widely in size, shape, material composition, and optical/electromagnetic properties [19], selecting an appropriate platform requires consideration of factors such as particle size for target access, carrier biocompatibility to reduce toxicity, and stability to prevent premature aggregation or degradation [19]